3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Hemorrhage
2
Chronic Pain
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Seizures
1
Radiodermatitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Parathyroid Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Interventions
vapreotide
1
Wound Closure Techniques
1
World Health Organization oral rehydration solution
1
Tranexamic Acid
1
Tracheostomy
1
Therapeutics
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Ropivacaine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Neoadjuvant Therapy
1
Intermittent Pneumatic Compression Devices
1
Fondaparinux
1
Fluorouracil
1
Fibrin Tissue Adhesive
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Postoperative Complications
×
Sodium Chloride
×
Clear all
NCT02256228
2019-01-15
IPLA
Göteborg University
Phase 3
Completed
40 enrolled